The Endocrine Society today issued a Clinical Practice Guideline (CPG) advising against the usage of testosterone treatment in healthy women. Although the FDA approved testosterone therapy for the treatment of ailments affecting the testes, pituitary and hypothalamus, it has not been approved for treating age-associated decrease in testosterone levels. The U.S. National Institute on Aging is also anticipated to release the results of research on the safety of testosterone. The study involved about 800 older men with low testosterone and symptoms associated with this affliction, like testosterone replacement therapy cost in india (click this link now) sexual and physical dysfunction. Since the men's heart health was monitored, the research is expected to shed more light on the safety of testosterone treatment.
The recent conflicting findings on testosterone treatment prompted his team to conduct a sizeable systematic literature search for studies assessing the relationship between testosterone replacement therapy and cardiovascular events among men and Patel. An estimated 13 million men in America have problems with low testosterone, which happens when the body fails to make enough hormones as a result of a difficulty with the testicles or pituitary gland. This clarifies loss of energy, obvious aging and an individual's sudden weight gain.
And many girls have a knee-jerk suspicion that any hormone treatment can increase their risk of breast cancer. However, clinical studies show that testosterone not only does not raise a woman's risk of breast cancer , it may play a vital role in warding off the disease. Glaser thinks this will likely remain the status quo for a while, given the prohibitive cost of conducting the long term safety studies needed to acquire completer FDA approval.